Literature DB >> 12185176

Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology.

G Peters1, D G du Plessis, P R Humphrey.   

Abstract

Although neurological symptoms are common in Whipple's disease, patients rarely have a purely neurological presentation and involvement restricted to the central nervous system is uncommon. A 39 year old woman presented with a meningoencephalitic illness, which responded to penicillin. Eleven months later she developed recurrent stroke-like episodes. Patchy enhancing meningeal, cortical, and subcortical lesions thought to be vascular in origin developed within nine days of the onset of symptoms. No evidence was found of a cardiovascular source of emboli, vasculitis, or thrombophilic condition. A brain biopsy showed meningoencephalitic features suspicious of Whipple's disease associated with leptomeningeal arterial fibrosis and thrombosis. DNA polymerase chain reaction confirmed Tropheryma whippelii in both blood and brain tissue. The neurological manifestations of cerebral Whipple's disease are varied and very rarely include stroke-like symptoms. The pathogenesis of cerebral infarction in Whipple's disease is not well established but arterial fibrosis and endocarditis complicated by embolisation have been reported. This case emphasises the importance of early brain biopsy in unusual cases of stroke and illustrates the clinical utility of polymerase chain reaction to confirm Whipple's disease.

Entities:  

Mesh:

Year:  2002        PMID: 12185176      PMCID: PMC1738037          DOI: 10.1136/jnnp.73.3.336

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

Review 1.  Whipple disease.

Authors:  Elan D Louis
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  Whipple's disease presenting with neurological symptoms in an immunosuppressed patient.

Authors:  Martijn Weisfelt; Erik Oosterwerff; Mirjam Oosterwerff; Cees Verburgh
Journal:  BMJ Case Rep       Date:  2012-06-05

3.  MR imaging of central nervous system Whipple disease: a 15-year review.

Authors:  D F Black; A J Aksamit; J M Morris
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

4.  Neuro-Whipple confirmed five years after a presumptive diagnosis of a primitive CNS vasculitis.

Authors:  J El Helou; G Saliba; I Kolev; C Pierrot-Deseilligny
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

5.  Gamma delta T cell expansion in Whipple's disease with muscular granulomatous vasculitis.

Authors:  Didier Brönnimann; Marie-Anne Vandenhende; Jean-François Viallard
Journal:  Infection       Date:  2018-05-03       Impact factor: 3.553

6.  Neurologic manifestations of Whipple's disease.

Authors:  Mara M Lugassy; Elan D Louis
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 7.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

8.  Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis.

Authors:  Florence Fenollar; François Nicoli; Claire Paquet; Hubert Lepidi; Patrick Cozzone; Jean-Christophe Antoine; Jean Pouget; Didier Raoult
Journal:  BMC Infect Dis       Date:  2011-06-15       Impact factor: 3.090

9.  Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: a case report and review of the literature.

Authors:  Victor W Sung; Michael J Lyerly; Kenneth B Fallon; Khurram Bashir
Journal:  Brain Behav       Date:  2012-10-01       Impact factor: 2.708

10.  Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.

Authors:  Caroline Compain; Karim Sacre; Xavier Puéchal; Isabelle Klein; Denis Vital-Durand; Jean-Luc Houeto; Thomas De Broucker; Didier Raoult; Thomas Papo
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.